FFA
Founders Financial Alliance’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $365K | Sell |
819
-49
| -6% | -$21.8K | 0.08% | 225 |
|
|
2025
Q1 | $421K | Buy |
+868
| New | +$421K | 0.1% | 203 |
|
|
2024
Q1 | – | Sell |
-1,136
| Closed | -$462K | – | 575 |
|
|
2023
Q4 | $462K | Sell |
1,136
-440
| -28% | -$179K | 0.18% | 112 |
|
|
2023
Q3 | $548K | Sell |
1,576
-72
| -4% | -$25K | 0.24% | 94 |
|
|
2023
Q2 | $580K | Buy |
1,648
+88
| +6% | +$31K | 0.23% | 94 |
|
|
2023
Q1 | $507K | Sell |
1,560
-44
| -3% | -$14.3K | 0.25% | 95 |
|
|
2022
Q4 | $463K | Sell |
1,604
-20
| -1% | -$5.78K | 0.21% | 109 |
|
|
2022
Q3 | $470K | Buy |
+1,624
| New | +$470K | 0.24% | 99 |
|
|
2022
Q1 | – | Sell |
-2,487
| Closed | -$546K | – | 482 |
|
|
2021
Q4 | $546K | Buy |
+2,487
| New | +$546K | 0.22% | 105 |
|
|
2021
Q3 | – | Sell |
-2,361
| Closed | -$477K | – | 484 |
|
|
2021
Q2 | $477K | Buy |
2,361
+94
| +4% | +$19K | 0.22% | 107 |
|
|
2021
Q1 | $488K | Buy |
2,267
+340
| +18% | +$73.2K | 0.24% | 92 |
|
|
2020
Q4 | $456K | Buy |
1,927
+1,883
| +4,280% | +$446K | 0.26% | 90 |
|
|
2020
Q3 | $12K | Buy |
+44
| New | +$12K | 0.01% | 728 |
|